Mumbai (Maharashtra) [India], January 3 (ANI/PRNewswire): Datar Cancer Genetics announced today that the US Food and Drug Administration (FDA) has granted 'Breakthrough Device Designation' for its 'TriNetra™-Glio', a blood test to help in the diagnosis of brain tumors. This is the thir
A new analysis has uncovered a potential link between higher prostate cancer risk and genetic variants associated with higher bloodstream levels of the cholesterol-transporting molecule lipoprotein A. Anna Ioannidou of Imperial College London, U.K., and colleagues present these findings in t
Researchers have described prostate cancer cell dynamics at a single-cell resolution across the whole course of the disease, from the first stages to the point of androgen independence, where the tumour stops responding to hormone restriction therapy.
From the onset of the disease through the point of androgen independence, where the tumour no longer responds to hormone restriction therapy, researchers have described prostate cancer cell dynamics at a single-cell resolution over the course of the disease.
Prostate cancer screening results differ in men taking cholesterol-lowering statin drugs compared with non-users, a study finds. In statin users, screening did not increase the incidence of prostate cancer as it did in other men.
Researchers at Imperial College London, University College London and Imperial College Healthcare NHS Trust have found that a new type of ultrasound scan can diagnose most prostate cancer cases with good accuracy in a clinical trial involving 370 men.
Washington [US], October 4 (ANI): Scientists at the Garvan Institute of Medical Research have discovered new epigenetic biomarkers to predict more aggressive forms of prostate cancer.
Washington [US], October 1 (ANI): A group of researchers discovered a novel role for a cancer-causing gene in controlling an important genetic process that underpins genetic variation in prostate cancer.
Washington [US], September 27 (ANI): A novel role for a cancer-causing gene in controlling an important genetic process that underpins genetic variation in prostate cancer has been identified by researchers from Barts Cancer Institute (BCI) at Queen Mary University of London, the Italian Ins